Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"

NCT01030861 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

NIH

Sponsor class

Conditions

Autoantibody Positive
Non-diabetic Relatives at Risk for Type 1 Diabetes
High Risk
Impaired Glucose Tolerance

Interventions

DRUG: Teplizumab
DRUG: Placebo infusion

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]